3.9 Editorial Material

Innovations and Challenges in the Treatment of Metastatic Triple-Negative Breast Cancer

Journal

JOURNAL OF ONCOLOGY PRACTICE
Volume 14, Issue 5, Pages 290-+

Publisher

AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JOP.18.00224

Keywords

-

Categories

Funding

  1. Bristol-Myers Squibb
  2. MedImmune
  3. ZIOPHARM Oncology
  4. Eli Lilly
  5. Merck

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available